These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway. Kim WS; Kim H; Jeong EM; Kim HJ; Lee ZH; Kim IG; Kim HH Sci Rep; 2017 Sep; 7(1):10626. PubMed ID: 28878266 [TBL] [Abstract][Full Text] [Related]
5. Immunologic regulation of bone development. Horowitz MC; Lorenzo JA Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387 [TBL] [Abstract][Full Text] [Related]
6. C/EBPα regulates osteoclast lineage commitment. Chen W; Zhu G; Hao L; Wu M; Ci H; Li YP Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7294-9. PubMed ID: 23580622 [TBL] [Abstract][Full Text] [Related]
7. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways. Hama M; Kirino Y; Takeno M; Takase K; Miyazaki T; Yoshimi R; Ueda A; Itoh-Nakadai A; Muto A; Igarashi K; Ishigatsubo Y Arthritis Rheum; 2012 May; 64(5):1518-28. PubMed ID: 22127667 [TBL] [Abstract][Full Text] [Related]
8. Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) axis. Shin B; Yu J; Park ES; Choi S; Yu J; Hwang JM; Yun H; Chung YH; Hong KS; Choi JS; Takami M; Rho J J Biol Chem; 2014 Dec; 289(52):35868-81. PubMed ID: 25359771 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1. Kim K; Kim TH; Ihn HJ; Kim JE; Choi JY; Shin HI; Park EK Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463002 [TBL] [Abstract][Full Text] [Related]
10. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684 [TBL] [Abstract][Full Text] [Related]
11. SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion. Zhou Y; Mohan A; Moore DC; Lin L; Zhou FL; Cao J; Wu Q; Qin YX; Reginato AM; Ehrlich MG; Yang W FASEB J; 2015 May; 29(5):1635-45. PubMed ID: 25593124 [TBL] [Abstract][Full Text] [Related]
12. Chaetocin inhibits RANKL-induced osteoclast differentiation through reduction of Blimp1 in Raw264.7 cells. Zhao N; Tsuda H; Murofushi T; Imai K; Ochiai K; Yang P; Suzuki N Life Sci; 2015 Dec; 143():1-7. PubMed ID: 26514304 [TBL] [Abstract][Full Text] [Related]
13. Early estrogen-induced gene 1 facilitates osteoclast formation through the inhibition of interferon regulatory factor 8 expression. Jeong E; Kim J; Go M; Lee SY FASEB J; 2020 Sep; 34(9):12894-12906. PubMed ID: 32741026 [TBL] [Abstract][Full Text] [Related]
14. Human BSAP and BLIMP1 conform an autoregulatory feedback loop. Mora-López F; Reales E; Brieva JA; Campos-Caro A Blood; 2007 Nov; 110(9):3150-7. PubMed ID: 17682124 [TBL] [Abstract][Full Text] [Related]
15. IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1). Chen Z; Su L; Xu Q; Katz J; Michalek SM; Fan M; Feng X; Zhang P J Biol Chem; 2015 Dec; 290(50):30163-74. PubMed ID: 26483549 [TBL] [Abstract][Full Text] [Related]
16. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12. Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868 [TBL] [Abstract][Full Text] [Related]
17. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. Dela Cruz A; Grynpas MD; Mitchell J Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198 [TBL] [Abstract][Full Text] [Related]
18. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
19. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Hikata T; Takaishi H; Takito J; Hakozaki A; Furukawa M; Uchikawa S; Kimura T; Okada Y; Matsumoto M; Yoshimura A; Nishimura R; Reddy SV; Asahara H; Toyama Y Blood; 2009 Mar; 113(10):2202-12. PubMed ID: 18952894 [TBL] [Abstract][Full Text] [Related]
20. PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice. Choi JH; Jang AR; Kim DI; Park MJ; Lim SK; Kim MS; Park JH Exp Mol Med; 2018 Aug; 50(8):1-15. PubMed ID: 30154485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]